Jie Jiang

4.8k total citations · 1 hit paper
143 papers, 3.1k citations indexed

About

Jie Jiang is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Jie Jiang has authored 143 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 32 papers in Cancer Research and 28 papers in Epidemiology. Recurrent topics in Jie Jiang's work include Cancer-related molecular mechanisms research (14 papers), Endometrial and Cervical Cancer Treatments (13 papers) and Ovarian cancer diagnosis and treatment (12 papers). Jie Jiang is often cited by papers focused on Cancer-related molecular mechanisms research (14 papers), Endometrial and Cervical Cancer Treatments (13 papers) and Ovarian cancer diagnosis and treatment (12 papers). Jie Jiang collaborates with scholars based in China, United States and Qatar. Jie Jiang's co-authors include Zhibin Hu, Jiahuai Hu, Nian Wang, Zhiming Liu, Chunping Qiu, Beihua Kong, Juan Wen, Wenzhi Li, Hongbing Shen and Yankai Xia and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jie Jiang

132 papers receiving 3.1k citations

Hit Papers

The Role of Oxidative Stress in Hyperuricemia and Xanthin... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors
    2021 160 citations Jie Jiang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jie Jiang China 33 1.2k 658 527 469 452 143 3.1k
Lei Yan China 23 1.5k 1.3× 1.3k 2.0× 219 0.4× 312 0.7× 339 0.8× 77 2.9k
Jinping Li China 23 872 0.8× 231 0.4× 858 1.6× 317 0.7× 180 0.4× 85 2.8k
Bin Guan United States 29 1.9k 1.6× 451 0.7× 323 0.6× 588 1.3× 571 1.3× 95 4.6k
Yin Yin China 29 860 0.7× 546 0.8× 471 0.9× 269 0.6× 127 0.3× 86 2.4k
Yan Zhang China 36 2.2k 1.9× 1.1k 1.6× 328 0.6× 953 2.0× 149 0.3× 245 4.5k
Jacek Nikliński Poland 31 1.7k 1.5× 968 1.5× 228 0.4× 952 2.0× 169 0.4× 170 3.6k
Li Qin China 33 2.1k 1.8× 1.0k 1.6× 227 0.4× 811 1.7× 87 0.2× 97 3.8k
Fang Ren China 30 1.4k 1.2× 879 1.3× 292 0.6× 449 1.0× 294 0.7× 139 2.6k
Tsukasa Suzuki Japan 34 1.9k 1.7× 245 0.4× 388 0.7× 197 0.4× 512 1.1× 133 3.9k
Jing Lü China 28 1.3k 1.1× 525 0.8× 212 0.4× 556 1.2× 112 0.2× 152 2.6k

Countries citing papers authored by Jie Jiang

Since Specialization
Citations

This map shows the geographic impact of Jie Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Jiang more than expected).

Fields of papers citing papers by Jie Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Jiang. The network helps show where Jie Jiang may publish in the future.

Co-authorship network of co-authors of Jie Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Jiang. A scholar is included among the top collaborators of Jie Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Jiang. Jie Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Jin‐Yuan, Jingru Jiang, Jie Jiang, et al.. (2025). Patient-reported outcomes of rimegepant for acute and preventive treatment of migraine in China: a prospective, multicenter, real-world study. The Journal of Headache and Pain. 26(1). 242–242.
3.
Sun, Rui, Ying Zhao, Yao Liu, et al.. (2025). Extracellular matrix stiffness in endometrial cancer: driving progression and modulating treatment sensitivity via the ROCK1/YAP1 axis. Cell Death and Disease. 16(1). 380–380. 2 indexed citations
4.
Hu, Wei, et al.. (2024). Interferon signaling and ferroptosis in tumor immunology and therapy. npj Precision Oncology. 8(1). 177–177. 7 indexed citations
5.
Xie, Qianqian, Xi Liu, Jie Jiang, et al.. (2024). Synthetic vectors for activating the driving axis of ferroptosis. Nature Communications. 15(1). 7923–7923. 6 indexed citations
6.
Zhou, Qing, Wenzhi Li, Yao Liu, et al.. (2023). LncRNA HOXB-AS3 binding to PTBP1 protein regulates lipid metabolism by targeting SREBP1 in endometrioid carcinoma. Life Sciences. 320. 121512–121512. 7 indexed citations
7.
Chen, Shuzhen, Yaping Dong, Ying Wang, et al.. (2023). Multi-dimensional single-cell characterization revealed suppressive immune microenvironment in AFP-positive hepatocellular carcinoma. Cell Discovery. 9(1). 60–60. 58 indexed citations
8.
Pan, Yongsheng, Cheng Shen, Xinfeng Chen, et al.. (2023). bpMRI and mpMRI for detecting prostate cancer: A retrospective cohort study. Frontiers in Surgery. 9. 1096387–1096387. 2 indexed citations
9.
Chen, Ping, Linlin Tang, Yun Song, et al.. (2023). Association of folic acid dosage with circulating unmetabolized folic acid in Chinese adults with H-type hypertension: a multicenter, double-blind, randomized controlled trial. Frontiers in Nutrition. 10. 1191610–1191610. 5 indexed citations
10.
Wei, Lina, Xiaohong Ma, Yixin Hou, et al.. (2023). Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma. Cell Death Discovery. 9(1). 30–30. 18 indexed citations
11.
12.
Ma, Xiaohong, Min Xia, Lina Wei, et al.. (2022). ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL. Cell Death and Disease. 13(12). 1067–1067. 8 indexed citations
13.
Chen, Yu, Zhi Xie, Jie Jiang, et al.. (2021). High SHP2 expression determines the efficacy of PD‐1/PD‐L1 inhibitors in advanced KRAS mutant non‐small cell lung cancer. Thoracic Cancer. 12(19). 2564–2573. 9 indexed citations
14.
Ma, Xiaohong, Tianyi Zhao, Hong Yan, et al.. (2021). Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma. Cell Death and Disease. 12(6). 544–544. 42 indexed citations
15.
16.
Zhou, Qing, Wenzhi Li, Zhiming Liu, et al.. (2019). DACH1 suppresses epithelial to mesenchymal transition (EMT) through Notch1 pathway and reverses progestin resistance in endometrial carcinoma. Cancer Medicine. 8(9). 4380–4388. 16 indexed citations
17.
Mi, Yanjun, et al.. (2016). Experimental study on inhibitory effects of Brucea javanica oil emulsion against lung cells. 36(4). 304. 1 indexed citations
18.
Sun, Hengzi, Yifang Zhang, Xiaoxia Che, et al.. (2015). Biglycan enhances the ability of migration and invasion in endometrial cancer. Archives of Gynecology and Obstetrics. 293(2). 429–438. 42 indexed citations
19.
Ghiabi, Pegah, Jie Jiang, Jennifer Pasquier, et al.. (2014). Endothelial Cells Provide a Notch-Dependent Pro-Tumoral Niche for Enhancing Breast Cancer Survival, Stemness and Pro-Metastatic Properties. PLoS ONE. 9(11). e112424–e112424. 67 indexed citations
20.
Deng, Xukun, et al.. (2014). Anti-Tumor Effects of Flavonoids from the Ethnic Medicine Docynia delavayi (Franch.) Schneid. and Its Possible Mechanism. Journal of Medicinal Food. 17(7). 787–794. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lei Yan Breakdown of academic impact, for papers by Jinping Li Breakdown of academic impact, for papers by Bin Guan Breakdown of academic impact, for papers by Yin Yin Breakdown of academic impact, for papers by Yan Zhang Breakdown of academic impact, for papers by Jacek Nikliński Breakdown of academic impact, for papers by Li Qin Breakdown of academic impact, for papers by Fang Ren Breakdown of academic impact, for papers by Tsukasa Suzuki Breakdown of academic impact, for papers by Jing Lü
Rankless by CCL
2026